Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3170)
All Articles published online
|
Jan 7, 2008 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wakabayashi H, Nishiyama Y, Otani T, Sano T, Yachida S, Okano K, Izuishi K, Suzuki Y. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. World J Gastroenterol 2008; 14(1): 64-69 [PMID: 18176963 DOI: 10.3748/wjg.14.64] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v14/i1/64.htm |
| Number | Citing Articles |
| 1 |
Gaia Grassetto, Domenico Rubello. Role of FDG-PET/CT in Diagnosis, Staging, Response to Treatment, and Prognosis of Pancreatic Cancer. American Journal of Clinical Oncology 2011; 34(2): 111 doi: 10.1097/COC.0b013e3181d275a0
|
| 2 |
Sang Mi Lee, Tae-Sung Kim, Jeong Won Lee, Seok-Ki Kim, Sang-Jae Park, Sung-Sik Han. Improved Prognostic Value of Standardized Uptake Value Corrected for Blood Glucose Level in Pancreatic Cancer Using F-18 FDG PET. Clinical Nuclear Medicine 2011; 36(5): 331 doi: 10.1097/RLU.0b013e31820a9eea
|
| 3 |
|
| 4 |
Woohyun Jung, Jin-Young Jang, Mee Joo Kang, Ye Rim Chang, Yong Chan Shin, Jihoon Chang, Sun-Whe Kim. The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography–computed tomography (PET–CT) in follow-up of curatively resected pancreatic cancer patients. HPB 2016; 18(1): 57 doi: 10.1016/j.hpb.2015.06.001
|
| 5 |
Sung Jun Ahn, Mi-Suk Park, Jong Doo Lee, Won Jun Kang. Correlation between 18F-fluorodeoxyglucose positron emission tomography and pathologic differentiation in pancreatic cancer. Annals of Nuclear Medicine 2014; 28(5): 430 doi: 10.1007/s12149-014-0833-x
|
| 6 |
Randy Yeh, Jonathan Steinman, Lyndon Luk, Michael D. Kluger, Elizabeth M. Hecht. Imaging of pancreatic cancer: what the surgeon wants to know. Clinical Imaging 2017; 42: 203 doi: 10.1016/j.clinimag.2016.10.002
|
| 7 |
Ho Seok I, Seong-Jang Kim, In Joo Kim, Keunyoung Kim. Predictive Value of Metabolic Tumor Volume Measured by 18F-FDG PET for Regional Lymph Node Status in Patients With Esophageal Cancer. Clinical Nuclear Medicine 2012; 37(5): 442 doi: 10.1097/RLU.0b013e318238f703
|
| 8 |
Shun Zhang, Yi-Ming Wang, Chuan-Dong Sun, Yun Lu, Li-Qun Wu. Clinical value of serum CA19-9 levels in evaluating resectability of pancreatic carcinoma. World Journal of Gastroenterology 2008; 14(23): 3750-3753 doi: 10.3748/wjg.14.3750
|
| 9 |
Jin-Ping Lai, Yong Yue, Wei Zhang, Yihua Zhou, David Frishberg, Laith H. Jamil, James M. Mirocha, Maha Guindi, Bonnie Balzer, Shikha Bose, Dengfeng Cao, Simon Lo, Xuemo Fan, Joanne K. Rutgers. Comparison of endoscopic ultrasound guided fine needle aspiration and PET/CT in preoperative diagnosis of pancreatic adenocarcinoma. Pancreatology 2017; 17(4): 617 doi: 10.1016/j.pan.2017.04.008
|
| 10 |
Paul F. Laeseke, Ru Chen, R. Brooke Jeffrey, Teresa A. Brentnall, Jürgen K. Willmann. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions. Radiology 2015; 277(3): 644 doi: 10.1148/radiol.2015141020
|
| 11 |
Jian Zhang, Chang-Jing Zuo, Ning-Yang Jia, Jian-Hua Wang, Sheng-Ping Hu, Zhong-Fei Yu, Yuan Zheng, An-Yu Zhang, Xiao-Yuan Feng. Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer. World Journal of Gastroenterology 2015; 21(10): 2988-2996 doi: 10.3748/wjg.v21.i10.2988
|
| 12 |
Todd M. Blodgett, Sanjay Paidisetty, Paul Shreve. Clinical PET-CT in Radiology. 2011; : 407 doi: 10.1007/978-0-387-48902-5_31
|
| 13 |
P.M. Vineeth Kumar, G.R. Verma, B.R. Mittal, Kanhaiyalal Agrawal, Rahul Gupta, Rakesh Kochhar, Virendra Singh, Lileshwar Kaman, Rajinder Singh. FLT PET/CT Is Better Than FDG PET/CT in Differentiating Benign From Malignant Pancreatobiliary Lesions. Clinical Nuclear Medicine 2016; 41(5): e244 doi: 10.1097/RLU.0000000000001163
|
| 14 |
Xiao-Yi Wang, Feng Yang, Chen Jin, De-Liang Fu. Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer. World Journal of Gastroenterology 2014; 20(42): 15580-15589 doi: 10.3748/wjg.v20.i42.15580
|
| 15 |
Ippei Matsumoto, Sachiyo Shirakawa, Makoto Shinzeki, Sadaki Asari, Tadahiro Goto, Tetsuo Ajiki, Takumi Fukumoto, Kazuhiko Kitajima, Yonson Ku. 18-Fluorodeoxyglucose Positron Emission Tomography Does Not Aid in Diagnosis of Pancreatic Ductal Adenocarcinoma. Clinical Gastroenterology and Hepatology 2013; 11(6): 712 doi: 10.1016/j.cgh.2012.12.033
|
| 16 |
Aparna Balachandran, Priya Bhosale, Chuslip Charnsangavej. Pancreatic Cancer. 2010; : 703 doi: 10.1007/978-0-387-77498-5_29
|
| 17 |
Keiichi Okano, Hironobu Suto, Minoru Oshima, Yasuhisa Ando, Mina Nagao, Hideki Kamada, Hideki Kobara, Tsutomu Masaki, Hiroyuki Okuyama, Yoshihiro Okita, Akihito Tsuji, Yasuyuki Suzuki. 18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer. Japanese Journal of Clinical Oncology 2018; 48(5): 434 doi: 10.1093/jjco/hyy033
|
| 18 |
Daniella F. Pinho, Rathan M. Subramaniam. PET–Computed Tomography and Precision Medicine in Pancreatic Adenocarcinoma and Pancreatic Neuroendocrine Tumors. PET Clinics 2017; 12(4): 407 doi: 10.1016/j.cpet.2017.05.003
|
| 19 |
Sampath Santhosh, Bhagwant Rai Mittal, Surinder Singh Rana, Radhika Srinivasan, Anish Bhattacharya, Ashim Das, Deepak Bhasin. Metabolic signatures of malignant and non-malignant mass-forming lesions in the periampulla and pancreas in FDG PET/CT scan: an atlas with pathologic correlation. Abdominal Imaging 2015; 40(5): 1285 doi: 10.1007/s00261-014-0266-y
|
| 20 |
Anna Maria De Gaetano, Vittoria Rufini, Paola Castaldi, Anna Maria Gatto, Laura Filograna, Alessandro Giordano, Lorenzo Bonomo. Clinical applications of 18F-FDG PET in the management of hepatobiliary and pancreatic tumors. Abdominal Imaging 2012; 37(6): 983 doi: 10.1007/s00261-012-9845-y
|
| 21 |
K. Tabata, A. Nishie, Y. Shimomura, T. Isoda, Y. Kitamura, K. Nakata, Y. Yamada, Y. Oda, K. Ishigami, S. Baba. Prediction of pathological response to preoperative chemotherapy for pancreatic ductal adenocarcinoma using 2-[18F]-fluoro-2-deoxy-d-glucose positron-emission tomography. Clinical Radiology 2022; 77(6): 436 doi: 10.1016/j.crad.2022.03.001
|
| 22 |
C. Pery, G. Meurette, C. Ansquer, E. Frampas, N. Regenet. Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions. Gastroentérologie Clinique et Biologique 2010; 34(8-9): 465 doi: 10.1016/j.gcb.2009.04.014
|
| 23 |
Saila P. Kauhanen, Gaber Komar, Marko P. Seppänen, Kirsti I. Dean, Heikki R. Minn, Sami A. Kajander, Irina Rinta-Kiikka, Kalle Alanen, Ronald J. Borra, Pauli A. Puolakkainen, Pirjo Nuutila, Jari T. Ovaska. A Prospective Diagnostic Accuracy Study of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Multidetector Row Computed Tomography, and Magnetic Resonance Imaging in Primary Diagnosis and Staging of Pancreatic Cancer. Annals of Surgery 2009; 250(6): 957 doi: 10.1097/SLA.0b013e3181b2fafa
|
| 24 |
Farzad Alemi, Adnan Alseidi, W. Scott Helton, Flavio G. Rocha. Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma. Current Problems in Surgery 2015; 52(9): 362 doi: 10.1067/j.cpsurg.2015.07.003
|
| 25 |
Domenico Tamburrino, Deniece Riviere, Mohammad Yaghoobi, Brian R Davidson, Kurinchi Selvan Gurusamy. Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database of Systematic Reviews 2016; 2016(9) doi: 10.1002/14651858.CD011515.pub2
|
| 26 |
Francisco Sánchez-Bueno, Rocío García-Pérez, María Antonia Claver Valderas, Jesús de la Peña Moral, Laura Frutos Esteban, Eduardo Ortiz Ruiz, Matilde Fuster Quiñonero, Pascual Parrilla Paricio. Utilidad de la 18-fluorodeoxiglucosa en la tomografía por emisión de positrones-tomografía computarizada (PET-TC) preoperatoria en el diagnóstico precoz del cáncer de páncreas exocrino: estudio en 139 casos resecados. Cirugía Española 2016; 94(9): 511 doi: 10.1016/j.ciresp.2016.07.007
|
| 27 |
Lawrence MJ Best, Vishal Rawji, Stephen P Pereira, Brian R Davidson, Kurinchi Selvan Gurusamy. Imaging modalities for characterising focal pancreatic lesions. Cochrane Database of Systematic Reviews 2017; 2017(4) doi: 10.1002/14651858.CD010213.pub2
|
| 28 |
Seong-Jang Kim, In-Ju Kim, Kuen Tak Suh, Yong-Ki Kim, Jung Sub Lee. Prediction of Residual Disease of Spine Infection Using F-18 FDG PET/CT. Spine 2009; 34(22): 2424 doi: 10.1097/BRS.0b013e3181b1fd33
|
| 29 |
YoungSeok Seo, Mi-Sook Kim, SungYul Yoo, ChulKoo Cho, KwangMo Yang, HyungJun Yoo, ChulWon Choi, DongHan Lee, Jin Kim, Min Suk Kim, HyeJin Kang, YoungHan Kim. Stereotactic Body Radiation Therapy Boost in Locally Advanced Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics 2009; 75(5): 1456 doi: 10.1016/j.ijrobp.2009.01.042
|
| 30 |
A.P. Rijkers, R. Valkema, H.J. Duivenvoorden, C.H.J. van Eijck. Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: A meta-analysis. European Journal of Surgical Oncology (EJSO) 2014; 40(7): 794 doi: 10.1016/j.ejso.2014.03.016
|
| 31 |
Peter Einersen, Irene Epelboym, Megan D. Winner, David Leung, John A. Chabot, John D. Allendorf. Positron Emission Tomography (PET) has Limited Utility in the Staging of Pancreatic Adenocarcinoma. Journal of Gastrointestinal Surgery 2014; 18(8): 1441 doi: 10.1007/s11605-014-2529-x
|
| 32 |
A.-C. Lefebvre, J. Maurel, S. Boutreux, V. Bouvier, J.-M. Reimund, G. Launoy, D. Arsene. Pancreatic cancer: Incidence, treatment and survival trends – 1175 cases in Calvados (France) from 1978 to 2002. Gastroentérologie Clinique et Biologique 2009; 33(10-11): 1045 doi: 10.1016/j.gcb.2009.04.011
|
| 33 |
Makoto Sakane, Mitsuaki Tatsumi, Masatoshi Hori, Hiromitsu Onishi, Takahiro Tsuboyama, Atsushi Nakamoto, Takashi Ota, Hidetoshi Eguchi, Kenichi Wakasa, Jun Hatazawa, Noriyuki Tomiyama. Volumetric parameters of 2-deoxy-2-[18F]fluoro- d -glucose positron emission tomography/computed tomography can predict histopathologic treatment response after neoadjuvant chemoradiotherapy in pancreatic adenocarcinoma. European Journal of Radiology 2017; 94: 64 doi: 10.1016/j.ejrad.2017.05.021
|
| 34 |
Nikhil Gupta, Raghav Yelamanchi. Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management. World Journal of Gastroenterology 2021; 27(23): 3158-3181 doi: 10.3748/wjg.v27.i23.3158
|
| 35 |
Bo Hyun Kim, In Joo Kim, Sang Soo Kim, Seong-Jang Kim, Chang Hun Lee, Yong-Ki Kim. Relationship Between Biological Marker Expression and Fluorine-18 Fluorodeoxyglucose Uptake in Incidentally Detected Thyroid Cancer. Cancer Biotherapy and Radiopharmaceuticals 2010; 25(3): 309 doi: 10.1089/cbr.2009.0636
|
| 36 |
Mingxing Wang, Yunyun Xu, Min Yang, Dingyi Jiang, Yunwang Chen, Jiahong Jiang, Zheling Chen, Liu Yang, Dongsheng Huang. Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature Review. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.579239
|
| 37 |
Sampath Santhosh, Bhagwant Rai Mittal, Deepak Bhasin, Radhika Srinivasan, Surinder Rana, Ashim Das, Ritambhra Nada, Anish Bhattacharya, Rajesh Gupta, Rakesh Kapoor. Role of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: Experience from tropics. Journal of Gastroenterology and Hepatology 2013; 28(2): 255 doi: 10.1111/jgh.12068
|
| 38 |
|
| 39 |
Kazuhiro Kitajima, Koji Murakami, Erena Yamasaki, Yasushi Kaji, Mitsugi Shimoda, Keiichi Kubota, Narufumi Suganuma, Kazuro Sugimura. Performance of Integrated FDG-PET/Contrast-enhanced CT in the Diagnosis of Recurrent Pancreatic Cancer: Comparison with Integrated FDG-PET/Non-contrast-enhanced CT and Enhanced CT. Molecular Imaging and Biology 2010; 12(4): 452 doi: 10.1007/s11307-009-0271-7
|
| 40 |
C. Buffet. Cancer du pancréas exocrine : clinique, bilan diagnostique et préthérapeutique. EMC - Hépatologie 2009; 4(2): 1 doi: 10.1016/S1155-1976(09)48138-5
|
| 41 |
Man Soo Yun, Seong-Jang Kim, Kyoungjune Pak, Chang Hun Lee. Additional Prognostic Value of SUV<sub>max</sub> Measured by F-18 FDG PET/CT over Biological Marker Expressions in Surgically Resected Cervical Cancer Patients. Oncology Research and Treatment 2015; 38(9): 413 doi: 10.1159/000438959
|
| 42 |
Ali Zakaria, Bayan Al-Share, Jason B. Klapman, Aamir Dam. The Role of Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Cancer. Cancers 2022; 14(6): 1373 doi: 10.3390/cancers14061373
|
| 43 |
Francisco Sánchez-Bueno, Rocío García-Pérez, María Antonia Claver Valderas, Jesús de la Peña Moral, Laura Frutos Esteban, Eduardo Ortiz Ruiz, Matilde Fuster Quiñonero, Pascual Parrilla Paricio. Utility of 18 Fludeoxyglucose in Preoperative Positon-Emission Tomography-Computed Tomography (PET-CT) in the Early Diagnosis of Exocrine Pancreatic Cancer: A Study of 139 Resected Cases. Cirugía Española (English Edition) 2016; 94(9): 511 doi: 10.1016/j.cireng.2016.11.006
|
| 44 |
Cosimo Sperti, Claudio Pasquali, Sergio Bissoli, Franca Chierichetti, Guido Liessi, Sergio Pedrazzoli. Tumor Relapse after Pancreatic Cancer Resection is Detected Earlier by 18-FDG PET than by CT. Journal of Gastrointestinal Surgery 2010; 14(1): 131 doi: 10.1007/s11605-009-1010-8
|
| 45 |
Seong-Jang Kim, Yong-Ki Kim, In Joo Kim, Young Dae Kim, Min Ki Lee. Limited Predictive Value of Dual-Time-Point F-18 FDG PET/CT for Evaluation of Pathologic N1 Status in NSCLC Patients. Clinical Nuclear Medicine 2011; 36(6): 434 doi: 10.1097/RLU.0b013e31820adef8
|
| 46 |
Sang I. Park, Dong S. Suh, Seong-Jang Kim, Kyung U. Choi, Man-Soo Yoon. Correlation between Biological Marker Expression and <sup>18</sup>F-Fluorodeoxyglucose Uptake in Cervical Cancer Measured by Positron Emission Tomography. Oncology Research and Treatment 2013; 36(4): 169 doi: 10.1159/000349944
|
| 47 |
Yizhen Pang, Long Zhao, Qihang Shang, Tinghua Meng, Liang Zhao, Liuxing Feng, Shuangjia Wang, Ping Guo, Xiurong Wu, Qin Lin, Hua Wu, Weipeng Huang, Long Sun, Haojun Chen. Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer. European Journal of Nuclear Medicine and Molecular Imaging 2022; 49(4): 1322 doi: 10.1007/s00259-021-05576-w
|
| 48 |
L. Wang, P. Dong, W.G. Wang, B.L. Tian. Positron emission tomography modalities prevent futile radical resection of pancreatic cancer: A meta-analysis. International Journal of Surgery 2017; 46: 119 doi: 10.1016/j.ijsu.2017.09.003
|
| 49 |
Bo Hyun Kim, Min A. Na, In Joo Kim, Seong-Jang Kim, Yong-Ki Kim. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Annals of Nuclear Medicine 2010; 24(10): 721 doi: 10.1007/s12149-010-0414-6
|
| 50 |
Kojun Okamoto, Isamu Koyama, Mitsuo Miyazawa, Yasuko Toshimitsu, Masayasu Aikawa, Katsuya Okada, Etsuko Imabayashi, Hiroshi Matsuda. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resection. International Journal of Clinical Oncology 2011; 16(1): 39 doi: 10.1007/s10147-010-0124-z
|
| 51 |
Seong-Jang Kim, Bo Hyun Kim, Yun Kyung Jeon, Sang Soo Kim, In Joo Kim. Limited diagnostic and predictive values of dual-time-point 18F FDG PET/CT for differentiation of incidentally detected thyroid nodules. Annals of Nuclear Medicine 2011; 25(5): 347 doi: 10.1007/s12149-011-0468-0
|
| 52 |
Randy Yeh, Laurent Dercle, Ishan Garg, Zhen Jane Wang, David M. Hough, Ajit H. Goenka. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma. Abdominal Radiology 2018; 43(2): 415 doi: 10.1007/s00261-017-1374-2
|
| 53 |
Lujaien A Kadhim, Avani S Dholakia, Joseph M Herman, Richard L Wahl, Muhammad A Chaudhry. The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma. Journal of Radiation Oncology 2013; 2(4): 341 doi: 10.1007/s13566-013-0130-7
|
| 54 |
Hye Jin Choi, Chang Moo Kang, Woo Jung Lee, Si Young Song, Arthur Cho, Mijin Yun, Jong Doo Lee, Joo Hang Kim, Jae-Hoon Lee. Prognostic Value of18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Resectable Pancreatic Cancer. Yonsei Medical Journal 2013; 54(6): 1377 doi: 10.3349/ymj.2013.54.6.1377
|